Syntaxin 4 heterozygous knockout mice develop muscle insulin resistance

Chunmei Yang, Kenneth J. Coker, Jason K. Kim, Silvia Mora, Debbie C. Thurmond, Ann C. Davis, Baoli Yang, Roger A. Williamson, Gerald I. Shulman, Jeffrey E. Pessin

Research output: Contribution to journalArticle

85 Citations (Scopus)

Abstract

To investigate the physiological function of syntaxin 4 in the regulation of GLUT4 vesicle trafficking, we used homologous recombination to generate syntaxin 4-knockout mice. Homozygotic disruption of the syntaxin 4 gene results in early embryonic lethality, whereas heterozygous knockout mice, Syn4+/-, had normal viability with no significant impairment in growth, development, or reproduction. However, the Syn4+/- mice manifested impaired glucose tolerance with a 50% reduction in whole-body glucose uptake. This defect was attributed to a 50% reduction in skeletal muscle glucose transport determined by 2-deoxyglucose uptake during hyperinsulinemic-euglycemic clamp procedures. In parallel, insulin-stimulated GLUT4 translocation in skeletal muscle was also significantly reduced in these mice. In contrast, Syn4+/- mice displayed normal insulin-stimulated glucose uptake and metabolism in adipose tissue and liver. Together, these data demonstrate that syntaxin 4 plays a critical physiological role in insulin-stimulated glucose uptake in skeletal muscle. Furthermore, reduction in syntaxin 4 protein levels in this tissue can account for the impairment in whole-body insulin-stimulated glucose metabolism in this animal model.

Original languageEnglish (US)
Pages (from-to)1311-1318
Number of pages8
JournalJournal of Clinical Investigation
Volume107
Issue number10
StatePublished - 2001
Externally publishedYes

Fingerprint

Qa-SNARE Proteins
Knockout Mice
Insulin Resistance
Glucose
Muscles
Insulin
Skeletal Muscle
Glucose Clamp Technique
Glucose Intolerance
Homologous Recombination
Deoxyglucose
Growth and Development
Reproduction
Adipose Tissue
Animal Models
Liver
Genes

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Yang, C., Coker, K. J., Kim, J. K., Mora, S., Thurmond, D. C., Davis, A. C., ... Pessin, J. E. (2001). Syntaxin 4 heterozygous knockout mice develop muscle insulin resistance. Journal of Clinical Investigation, 107(10), 1311-1318.

Syntaxin 4 heterozygous knockout mice develop muscle insulin resistance. / Yang, Chunmei; Coker, Kenneth J.; Kim, Jason K.; Mora, Silvia; Thurmond, Debbie C.; Davis, Ann C.; Yang, Baoli; Williamson, Roger A.; Shulman, Gerald I.; Pessin, Jeffrey E.

In: Journal of Clinical Investigation, Vol. 107, No. 10, 2001, p. 1311-1318.

Research output: Contribution to journalArticle

Yang, C, Coker, KJ, Kim, JK, Mora, S, Thurmond, DC, Davis, AC, Yang, B, Williamson, RA, Shulman, GI & Pessin, JE 2001, 'Syntaxin 4 heterozygous knockout mice develop muscle insulin resistance', Journal of Clinical Investigation, vol. 107, no. 10, pp. 1311-1318.
Yang C, Coker KJ, Kim JK, Mora S, Thurmond DC, Davis AC et al. Syntaxin 4 heterozygous knockout mice develop muscle insulin resistance. Journal of Clinical Investigation. 2001;107(10):1311-1318.
Yang, Chunmei ; Coker, Kenneth J. ; Kim, Jason K. ; Mora, Silvia ; Thurmond, Debbie C. ; Davis, Ann C. ; Yang, Baoli ; Williamson, Roger A. ; Shulman, Gerald I. ; Pessin, Jeffrey E. / Syntaxin 4 heterozygous knockout mice develop muscle insulin resistance. In: Journal of Clinical Investigation. 2001 ; Vol. 107, No. 10. pp. 1311-1318.
@article{186f0d21e57e432d8dea15cdbdda0d65,
title = "Syntaxin 4 heterozygous knockout mice develop muscle insulin resistance",
abstract = "To investigate the physiological function of syntaxin 4 in the regulation of GLUT4 vesicle trafficking, we used homologous recombination to generate syntaxin 4-knockout mice. Homozygotic disruption of the syntaxin 4 gene results in early embryonic lethality, whereas heterozygous knockout mice, Syn4+/-, had normal viability with no significant impairment in growth, development, or reproduction. However, the Syn4+/- mice manifested impaired glucose tolerance with a 50{\%} reduction in whole-body glucose uptake. This defect was attributed to a 50{\%} reduction in skeletal muscle glucose transport determined by 2-deoxyglucose uptake during hyperinsulinemic-euglycemic clamp procedures. In parallel, insulin-stimulated GLUT4 translocation in skeletal muscle was also significantly reduced in these mice. In contrast, Syn4+/- mice displayed normal insulin-stimulated glucose uptake and metabolism in adipose tissue and liver. Together, these data demonstrate that syntaxin 4 plays a critical physiological role in insulin-stimulated glucose uptake in skeletal muscle. Furthermore, reduction in syntaxin 4 protein levels in this tissue can account for the impairment in whole-body insulin-stimulated glucose metabolism in this animal model.",
author = "Chunmei Yang and Coker, {Kenneth J.} and Kim, {Jason K.} and Silvia Mora and Thurmond, {Debbie C.} and Davis, {Ann C.} and Baoli Yang and Williamson, {Roger A.} and Shulman, {Gerald I.} and Pessin, {Jeffrey E.}",
year = "2001",
language = "English (US)",
volume = "107",
pages = "1311--1318",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "10",

}

TY - JOUR

T1 - Syntaxin 4 heterozygous knockout mice develop muscle insulin resistance

AU - Yang, Chunmei

AU - Coker, Kenneth J.

AU - Kim, Jason K.

AU - Mora, Silvia

AU - Thurmond, Debbie C.

AU - Davis, Ann C.

AU - Yang, Baoli

AU - Williamson, Roger A.

AU - Shulman, Gerald I.

AU - Pessin, Jeffrey E.

PY - 2001

Y1 - 2001

N2 - To investigate the physiological function of syntaxin 4 in the regulation of GLUT4 vesicle trafficking, we used homologous recombination to generate syntaxin 4-knockout mice. Homozygotic disruption of the syntaxin 4 gene results in early embryonic lethality, whereas heterozygous knockout mice, Syn4+/-, had normal viability with no significant impairment in growth, development, or reproduction. However, the Syn4+/- mice manifested impaired glucose tolerance with a 50% reduction in whole-body glucose uptake. This defect was attributed to a 50% reduction in skeletal muscle glucose transport determined by 2-deoxyglucose uptake during hyperinsulinemic-euglycemic clamp procedures. In parallel, insulin-stimulated GLUT4 translocation in skeletal muscle was also significantly reduced in these mice. In contrast, Syn4+/- mice displayed normal insulin-stimulated glucose uptake and metabolism in adipose tissue and liver. Together, these data demonstrate that syntaxin 4 plays a critical physiological role in insulin-stimulated glucose uptake in skeletal muscle. Furthermore, reduction in syntaxin 4 protein levels in this tissue can account for the impairment in whole-body insulin-stimulated glucose metabolism in this animal model.

AB - To investigate the physiological function of syntaxin 4 in the regulation of GLUT4 vesicle trafficking, we used homologous recombination to generate syntaxin 4-knockout mice. Homozygotic disruption of the syntaxin 4 gene results in early embryonic lethality, whereas heterozygous knockout mice, Syn4+/-, had normal viability with no significant impairment in growth, development, or reproduction. However, the Syn4+/- mice manifested impaired glucose tolerance with a 50% reduction in whole-body glucose uptake. This defect was attributed to a 50% reduction in skeletal muscle glucose transport determined by 2-deoxyglucose uptake during hyperinsulinemic-euglycemic clamp procedures. In parallel, insulin-stimulated GLUT4 translocation in skeletal muscle was also significantly reduced in these mice. In contrast, Syn4+/- mice displayed normal insulin-stimulated glucose uptake and metabolism in adipose tissue and liver. Together, these data demonstrate that syntaxin 4 plays a critical physiological role in insulin-stimulated glucose uptake in skeletal muscle. Furthermore, reduction in syntaxin 4 protein levels in this tissue can account for the impairment in whole-body insulin-stimulated glucose metabolism in this animal model.

UR - http://www.scopus.com/inward/record.url?scp=0035000661&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035000661&partnerID=8YFLogxK

M3 - Article

C2 - 11375421

AN - SCOPUS:0035000661

VL - 107

SP - 1311

EP - 1318

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 10

ER -